IE38383B1 - Doxycline parenteral composition - Google Patents

Doxycline parenteral composition

Info

Publication number
IE38383B1
IE38383B1 IE1845/73A IE184573A IE38383B1 IE 38383 B1 IE38383 B1 IE 38383B1 IE 1845/73 A IE1845/73 A IE 1845/73A IE 184573 A IE184573 A IE 184573A IE 38383 B1 IE38383 B1 IE 38383B1
Authority
IE
Ireland
Prior art keywords
salt
doxycycline
composition
water
ascorbate
Prior art date
Application number
IE1845/73A
Other versions
IE38383L (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IE38383L publication Critical patent/IE38383L/en
Publication of IE38383B1 publication Critical patent/IE38383B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/65Tetracyclines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

1350196 Doxycycline parenteral composition PFIZER Inc 27 Dec 1972 [26 Oct 1972] 59710/72 Heading A5B Aqueous pharmaceutical compositions for parenteral administration comprise a solution in water of from 1 to 10% by weight of a pharmaceutically acceptable acid addition salt of doxycycline, together with at least 3 molar proportions of a water-soluble alkali metal phosphate salt, and at least 3 molar proportions of a pharmaceutically acceptable watersoluble magnesium salt, said composition having a pH value in the range of from 1.0 to 3.5 The doxycycline acid addition salt may be the hydrochloride, hydrochloride hemiethanolate hemihydrate, hydrobromide, sulphate, nitrate, ascorbate, citrate, gluconate, lactate, isonicotinate, gentisinate, pantothenate, salicylate, glucuronate, formate, or glutamate. The alkali metal phosphate salt may be sodium or potassium orthophosphate, metaphosphate, pyrophosphate, tripolyphosphate or hexametaphosphate and the magnesium salt may be magnesium chloride, glyconate, oxide, ascorbate or lactate. The pH value may be adjusted by ascorbic, tartaric, gluconic, glucuronic, citric, gentisic, isonicotinic or glutamic acid. The composition may also contain a water-soluble local anaesthetic such as procaine and lidocaine hydrochlorides. [GB1350196A]
IE1845/73A 1972-10-26 1973-10-16 Doxycline parenteral composition IE38383B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30123672A 1972-10-26 1972-10-26

Publications (2)

Publication Number Publication Date
IE38383L IE38383L (en) 1974-04-26
IE38383B1 true IE38383B1 (en) 1978-03-01

Family

ID=23162536

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1845/73A IE38383B1 (en) 1972-10-26 1973-10-16 Doxycline parenteral composition

Country Status (17)

Country Link
JP (1) JPS531815B2 (en)
AR (1) AR200582A1 (en)
BE (1) BE806261A (en)
CA (1) CA1005760A (en)
CH (1) CH583563A5 (en)
DE (1) DE2352910A1 (en)
DK (1) DK133084C (en)
FI (1) FI52269B (en)
FR (1) FR2204402B1 (en)
GB (1) GB1350196A (en)
IE (1) IE38383B1 (en)
KE (1) KE2568A (en)
MY (1) MY7500201A (en)
NL (1) NL162836C (en)
PH (1) PH9547A (en)
SE (1) SE411424B (en)
ZA (1) ZA738187B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0052404B1 (en) * 1980-11-19 1987-05-27 THE PROCTER & GAMBLE COMPANY Non-yellowing topical pharmaceutical composition
US5124317A (en) * 1985-08-02 1992-06-23 Farmitalia Carlo Erba S.P.A. Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
US5977082A (en) 1985-08-02 1999-11-02 Pharmacia & Upjohn Company Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
CN115844842A (en) * 2022-12-28 2023-03-28 江西省保灵动物保健品有限公司 Doxycycline hydrochloride tablet and preparation method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1767891C3 (en) * 1968-06-28 1980-10-30 Pfizer Process for the preparation of aqueous medicinal solutions for parenteral, peroral and local use containing a tetracycline derivative
ES396132A1 (en) * 1970-10-30 1972-12-01 Villax Complexes of a-6-deoxy-5-hydroxy tetracycline and their preparation

Also Published As

Publication number Publication date
PH9547A (en) 1976-01-16
AU6158973A (en) 1975-04-24
JPS4980226A (en) 1974-08-02
CA1005760A (en) 1977-02-22
ZA738187B (en) 1974-11-27
FR2204402A1 (en) 1974-05-24
IE38383L (en) 1974-04-26
BE806261A (en) 1974-04-19
CH583563A5 (en) 1977-01-14
DE2352910A1 (en) 1974-05-09
AR200582A1 (en) 1974-11-22
FR2204402B1 (en) 1976-08-13
MY7500201A (en) 1975-12-31
SE411424B (en) 1979-12-27
NL162836C (en) 1980-07-15
DK133084B (en) 1976-03-22
KE2568A (en) 1975-09-26
GB1350196A (en) 1974-04-18
JPS531815B2 (en) 1978-01-23
FI52269B (en) 1977-05-02
NL7314596A (en) 1974-05-01
NL162836B (en) 1980-02-15
DK133084C (en) 1976-08-16

Similar Documents

Publication Publication Date Title
US3957980A (en) Doxycycline parenteral compositions
GB1463966A (en) Depilatory formulation
KR930001915A (en) Pharmaceutical Compositions Suitable for the Treatment of Pancreatic Fibrosis and Chronic Pain Syndrome
HK1058622A1 (en) Pharmaceutical form of administration for peptides, method for its production and use
IE38383B1 (en) Doxycline parenteral composition
GB1380225A (en) Biphenylyl- alkanoylaminopyridines and acid addition salts thereof
GB1256968A (en)
GB1338071A (en) Pharmaceutical iron preparations
GB1346014A (en) Derivatives of alpha-ketoglutaric acid and their preparation
ES404959A1 (en) Aqueous doxycycline compositions
US3335055A (en) More stable and more soluble tetracycline compositions suitable for parenteral use and method of preparing same
GB1318478A (en) Cephalexin salts
GB1292410A (en) Thienobenzothiazepine derivatives
GB1365176A (en) Benzodiazepine derivatives
GB1322112A (en) 3,4,5-trimethoxybenzoic acid derivatives and their uses
ES375401A1 (en) Erythromycin aspartate salt
IE42060L (en) 2-deutero-3-fluoro-alanine
GB1415709A (en) Chlorinated mandelamidines
GB1427882A (en) Oxytetracycline solutions
GB1304137A (en)
GB1364366A (en) Derivatives of 4-chloro-5-sulphamoyl-anthranilic acid their preparation and pahamaceutical compositions comprising them
GB1394397A (en) Chlorphenesin derivatives and method of making same
GB1132287A (en) Antibiotic compositions
GB1381072A (en) 3-amino-as-triazino-6,5-quinoline and derivatives
GB1299289A (en) Piperidine derivatives